Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
34.36
-0.98 (-2.77%)
Sep 1, 2026, 4:08 PM HKT

HKG:3692 Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $47.54. The average 1-year stock price forecast is 38.36% higher than the current stock price, while the lowest is $37.25 (+8.41%) and the highest is $55.06 (+60.24%).

Price Target: $47.54 (+38.36%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$37.25$47.54$47.92$55.06
Change+8.41%+38.36%+39.46%+60.24%

Analyst Ratings

The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26Jun '26Jul '26Aug '26
Strong Buy181816161617
Buy555555
Hold111111
Sell110000
Strong Sell000000
Total252522222223

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
CMB International Securities
CMB International Securities
Buy
Maintains
$47.19$49.12
BuyMaintains$47.19$49.12+42.96%Aug 29, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$52.00
BuyMaintains$52.00+51.34%Aug 28, 2026
Unknown Analyst
Goldman Sachs
No rating
Goldman Sachs
Buy
Maintains
$50.10$52.70
BuyMaintains$50.10$52.70+53.38%Aug 27, 2026
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$44.68$44.66
BuyMaintains$44.68$44.66+29.98%Aug 27, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Buy
Maintains
$50.00
BuyMaintains$50.00+45.52%Aug 27, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
17.00B
from 15.03B
Increased by 13.13%
Revenue Next Year
18.56B
from 17.00B
Increased by 9.16%
EPS This Year
1.05
from 0.93
Increased by 13.17%
EPS Next Year
1.11
from 1.05
Increased by 5.26%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
9.94B9.38B10.10B12.26B15.03B17.00B
Revenue Growth
14.33%-5.56%7.69%21.35%22.57%13.13%
Gross Profit
9.06B8.51B9.07B11.14B13.51B15.44B
Gross Margin
91.24%90.73%89.78%90.89%89.89%90.84%
Operating Income
2.82B2.61B2.68B3.90B5.40B6.48B
Net Income
2.71B2.58B3.28B4.37B5.56B6.32B
EPS
----0.931.05
EPS Growth
----27.40%13.17%
Forward PE
27.0924.9728.3124.0536.2927.98
Dividend / Share
0.070.090.190.320.390.41
Dividend Growth
12.44%20.84%118.47%63.53%22.73%4.52%
Free Cash Flow
1.26B1.45B2.07B2.40B5.16B5.47B
No. Analysts
-----19
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High17.5B
Avg17.0B
Low16.6B

Revenue Growth

Revenue Growth202620272028
High
16.3%
Avg
13.1%
Low
10.6%

EPS Forecast

EPS202620272028
High1.19
Avg1.05
Low0.95

EPS Growth

EPS Growth202620272028
High
28.0%
Avg
13.2%
Low
2.2%